IL176932A0 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof - Google Patents
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereofInfo
- Publication number
- IL176932A0 IL176932A0 IL176932A IL17693206A IL176932A0 IL 176932 A0 IL176932 A0 IL 176932A0 IL 176932 A IL176932 A IL 176932A IL 17693206 A IL17693206 A IL 17693206A IL 176932 A0 IL176932 A0 IL 176932A0
- Authority
- IL
- Israel
- Prior art keywords
- dehydrophenylahistins
- analogs
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54207304P | 2004-02-04 | 2004-02-04 | |
US62426204P | 2004-11-01 | 2004-11-01 | |
PCT/US2005/003636 WO2005077940A1 (en) | 2004-02-04 | 2005-02-04 | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL176932A0 true IL176932A0 (en) | 2006-12-10 |
Family
ID=34864489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL176932A IL176932A0 (en) | 2004-02-04 | 2006-07-18 | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1711487A1 (en) |
JP (1) | JP2007520565A (en) |
KR (1) | KR101228104B1 (en) |
AU (1) | AU2005212399B2 (en) |
BR (1) | BRPI0506655A (en) |
CA (1) | CA2553630A1 (en) |
IL (1) | IL176932A0 (en) |
NZ (1) | NZ548659A (en) |
WO (1) | WO2005077940A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
DE60316688T2 (en) | 2002-08-02 | 2008-07-17 | Nereus Pharmaceuticals, Inc., San Diego | DEHYDROPHENYLAHISTINES AND ANALOGS THEREOF AND A PROCESS FOR THE PRODUCTION OF DEHYDROPHENYLAHISTINES AND ANALOGUE THEREOF |
US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
WO2007035841A1 (en) * | 2005-09-21 | 2007-03-29 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
KR102225371B1 (en) * | 2013-10-11 | 2021-03-10 | 비욘드스프링인크. | Cancer treatment with combination of plinabulin and taxane |
JP7243021B2 (en) * | 2015-02-12 | 2023-03-22 | ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド | Use of plinabulin in combination with immune checkpoint inhibitors |
RU2736045C2 (en) | 2015-03-06 | 2020-11-11 | Бейондспринг Фармасьютикалс, Инк. | Method of treating cancer associated with a ras mutation |
BR112017018964A2 (en) | 2015-03-06 | 2018-05-22 | Beyondspring Pharmaceuticals Inc | use of plinabulin and methods to treat brain tumor |
KR20180027563A (en) * | 2015-07-13 | 2018-03-14 | 비욘드스프링 파마수티컬스, 인코포레이티드. | Flinabuled composition |
SG11201806583XA (en) | 2016-02-08 | 2018-09-27 | Beyondspring Pharmaceuticals Inc | Compositions containing tucaresol or its analogs |
SG11201810872UA (en) | 2016-06-06 | 2019-01-30 | Beyondspring Pharmaceuticals Inc | Composition and method for reducing neutropenia |
CN114276332B (en) | 2016-08-12 | 2023-08-18 | 深圳华大海洋科技有限公司 | Polymorphic form of dehydrogenated phenyl-achyranthes and its preparing and purifying process and application |
JP2020503363A (en) | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド | Tubulin binding compounds and their therapeutic use |
AU2018217120B2 (en) | 2017-02-01 | 2024-02-08 | Beyondspring Pharmaceuticals, Inc. | Method of reducing neutropenia |
CN110603037A (en) * | 2017-03-13 | 2019-12-20 | 大连万春布林医药有限公司 | Plinabulin compositions and uses thereof |
JP7350015B2 (en) | 2018-01-24 | 2023-09-25 | ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド | Compositions and methods for reducing thrombocytopenia due to administration of plinabulin |
CN108524442B (en) * | 2018-06-05 | 2022-01-28 | 深圳海王医药科技研究院有限公司 | Injection of antineoplastic medicine and its preparing process |
JP2018199726A (en) * | 2018-09-26 | 2018-12-20 | ビヨンドスプリング インコーポレイテッド | Cancer treatment with combination of plinabulin and taxane |
WO2023060200A1 (en) * | 2021-10-07 | 2023-04-13 | Beyondspring Pharmaceuticals, Inc. | Methods for treating cancers and tumors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3318789A1 (en) * | 1983-05-24 | 1984-11-29 | Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke | DEODORANT |
GB9402807D0 (en) * | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
US6069146A (en) * | 1998-03-25 | 2000-05-30 | The Regents Of The University Of California | Halimide, a cytotoxic marine natural product, and derivatives thereof |
US6358957B1 (en) * | 1998-11-12 | 2002-03-19 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
WO2001053290A1 (en) * | 2000-01-18 | 2001-07-26 | Nippon Steel Corporation | Cell division inhibitors and process for producing the same |
US6635649B2 (en) * | 2000-05-09 | 2003-10-21 | Che-Ming Teng | Piperazinedione compounds |
DE60316688T2 (en) * | 2002-08-02 | 2008-07-17 | Nereus Pharmaceuticals, Inc., San Diego | DEHYDROPHENYLAHISTINES AND ANALOGS THEREOF AND A PROCESS FOR THE PRODUCTION OF DEHYDROPHENYLAHISTINES AND ANALOGUE THEREOF |
-
2005
- 2005-02-04 JP JP2006552282A patent/JP2007520565A/en active Pending
- 2005-02-04 BR BRPI0506655-7A patent/BRPI0506655A/en not_active IP Right Cessation
- 2005-02-04 AU AU2005212399A patent/AU2005212399B2/en not_active Ceased
- 2005-02-04 KR KR1020067017883A patent/KR101228104B1/en active IP Right Grant
- 2005-02-04 NZ NZ548659A patent/NZ548659A/en unknown
- 2005-02-04 EP EP05712910A patent/EP1711487A1/en not_active Withdrawn
- 2005-02-04 WO PCT/US2005/003636 patent/WO2005077940A1/en active Application Filing
- 2005-02-04 CA CA002553630A patent/CA2553630A1/en not_active Abandoned
-
2006
- 2006-07-18 IL IL176932A patent/IL176932A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR101228104B1 (en) | 2013-02-01 |
NZ548659A (en) | 2011-01-28 |
KR20060124743A (en) | 2006-12-05 |
WO2005077940A1 (en) | 2005-08-25 |
EP1711487A1 (en) | 2006-10-18 |
AU2005212399B2 (en) | 2011-09-22 |
BRPI0506655A (en) | 2007-05-08 |
AU2005212399A1 (en) | 2005-08-25 |
JP2007520565A (en) | 2007-07-26 |
CA2553630A1 (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176932A0 (en) | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof | |
IL217316A0 (en) | Synthesis of tetracyclines and analogs thereof | |
PT1778618E (en) | Synthesis of triethylenetetramines | |
EP1773871A4 (en) | Tdf-related compounds and analogs thereof | |
ZA200802501B (en) | Indenoisoquinolinone analogs and methods of use thereof | |
AP2006003768A0 (en) | TetraazabenzoÄeÜazulene derivatives and analogs tehereof | |
HK1164320A1 (en) | Synthesis of bortezomib | |
EP1785131A4 (en) | External preparation of s/o type | |
EP1968937A4 (en) | Deazapurine analogs of 1'-aza-l-nucleosides | |
EP1874731A4 (en) | Quinobenzoxazine analogs and methods of using thereof | |
EP1863800A4 (en) | Synthesis of avrainvillamide, stephacidin b, and analogues thereof | |
EP1711484A4 (en) | Synthesis of cyanoimino-benzoimidazoles | |
IL179462A0 (en) | Use of the receptor gpr86 | |
EP1727065A4 (en) | Event sequencer | |
EP1735281A4 (en) | Synthesis of indenoisoquinoliniums and methods of use | |
EP1945258A4 (en) | Tdf-related compounds and analogs thereof | |
HK1079776A1 (en) | The synthesis of 1,3-dihydro-2h-3-benzazepin-2-onecompounds, and the use thereof | |
GB2441840B (en) | Process for the synthesis of arylfluorenes and analogues thereof | |
IL189547A0 (en) | Synthesis of 1??-fluoro-25-hydroxy | |
EP1819715A4 (en) | Synthesis of cardiolipin analogues and uses thereof | |
EP1802560A4 (en) | Halocombstatins and methods of synthesis thereof | |
IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles | |
IL185691A0 (en) | Novel compounds derived from 5-thioxylose and therapeutic use thereof | |
PL377902A1 (en) | Novel use of phosphor-nitrogen-metal complex | |
AU2003217354A8 (en) | Synthesis of sulfamidates |